Paper39600720
Lactobacillus paracasei 259 alleviates hyperuricemia in rats by decreasing uric acid and modulating the gut microbiota.
Bi C and 3 others. Front Nutr, 2024. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Lactobacillus paracasei 259 alleviates hyperuricemia in rats by decreasing uric acid and modulating the gut microbiota. Papers, record 39600720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39600720
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lactobacillus paracasei 259 alleviates hyperuricemia in rats by decreasing uric acid and modulating the gut microbiota.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38674582 | Limosilactobacillus reuteri HCS02-001 Attenuates Hyperuricemia through Gut Microbiota-Dependent Regulation of Uric Acid Biosynthesis and Excretion. | Microorganisms | 2024 | https://conductscience.org/library/papers/38674582 | PubMed |
| 2 | 35630296 | Potential Probiotic Lacticaseibacillus paracasei MJM60396 Prevents Hyperuricemia in a Multiple Way by Absorbing Purine, Suppressing Xanthine Oxidase and Regulating Urate Excretion in Mice. | Microorganisms | 2022 | https://conductscience.org/library/papers/35630296 | PubMed |
| 3 | 35281005 | The Role of the Intestine in the Development of Hyperuricemia. | Front Immunol | 2022 | https://conductscience.org/library/papers/35281005 | PubMed |
| 4 | 29496260 | Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. | Am J Kidney Dis | 2018 | https://conductscience.org/library/papers/29496260 | PubMed |
| 5 | 37501367 | The interaction between hyperuricemia and low-density lipoprotein cholesterol increases the risk of 1-year post-discharge all-cause mortality in ST-segment elevation myocardial infarction patients. | Nutr Metab Cardiovasc Dis | 2023 | https://conductscience.org/library/papers/37501367 | PubMed |
| 6 | 38166872 | Dyslipidemia and hyperuricemia: a cross-sectional study of residents in Wuhu, China. | BMC Endocr Disord | 2024 | https://conductscience.org/library/papers/38166872 | PubMed |
| 7 | 33986988 | Lactobacillus reuteri TSR332 and Lactobacillus fermentum TSF331 stabilize serum uric acid levels and prevent hyperuricemia in rats. | PeerJ | 2021 | https://conductscience.org/library/papers/33986988 | PubMed |
| 8 | 35873427 | Effect and Potential Mechanism of Lactobacillus plantarum Q7 on Hyperuricemia in vitro and in vivo. | Front Nutr | 2022 | https://conductscience.org/library/papers/35873427 | PubMed |
| 9 | 36248735 | Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid. | iScience | 2022 | https://conductscience.org/library/papers/36248735 | PubMed |
| 10 | 29415757 | Soluble uric acid increases PDZK1 and ABCG2 expression in human intestinal cell lines via the TLR4-NLRP3 inflammasome and PI3K/Akt signaling pathway. | Arthritis Res Ther | 2018 | https://conductscience.org/library/papers/29415757 | PubMed |
| 11 | 31367212 | ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population. | Hereditas | 2019 | https://conductscience.org/library/papers/31367212 | PubMed |
| 12 | 30618180 | Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016. | Arthritis Rheumatol | 2019 | https://conductscience.org/library/papers/30618180 | PubMed |
| 13 | 30852460 | Lactobacillus brevis DM9218 ameliorates fructose-induced hyperuricemia through inosine degradation and manipulation of intestinal dysbiosis. | Nutrition | 2019 | https://conductscience.org/library/papers/30852460 | PubMed |
| 14 | 31822862 | Asymptomatic hyperuricaemia: a silent activator of the innate immune system. | Nat Rev Rheumatol | 2020 | https://conductscience.org/library/papers/31822862 | PubMed |
| 15 | 28088611 | Lactobacillus paracasei modulates LPS-induced inflammatory cytokine release by monocyte-macrophages via the up-regulation of negative regulators of NF-kappaB signaling in a TLR2-dependent manner. | Cytokine | 2017 | https://conductscience.org/library/papers/28088611 | PubMed |
| 16 | 36034697 | Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/36034697 | PubMed |
| 17 | 33764849 | Limosilactobacillus fermentum JL-3 isolated from "Jiangshui" ameliorates hyperuricemia by degrading uric acid. | Gut Microbes | 2021 | https://conductscience.org/library/papers/33764849 | PubMed |
| 18 | 32560339 | Associations of Serum Retinol and α-Tocopherol Levels with Uric Acid Concentrations: Analysis of a Population-Based, Nationally Representative Sample. | Nutrients | 2020 | https://conductscience.org/library/papers/32560339 | PubMed |
| 19 | 38492092 | Comparison of the efficacy and safety of benzbromarone and febuxostat in gout and hyperuricemia: a systematic review and meta-analysis. | Clin Rheumatol | 2024 | https://conductscience.org/library/papers/38492092 | PubMed |
| 20 | 35156670 | The potential of probiotics in the amelioration of hyperuricemia. | Food Funct | 2022 | https://conductscience.org/library/papers/35156670 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42883558 | From Efficacy to Process: Uric-Acid-Lowering Effect of Limosilactobacillus reuteri W6-12 and Its Production Process Optimization. | Foods | 2026 | https://conductscience.org/library/papers/42883558 | PubMed |
| 42197271 | Cold-Adapted Uric Acid-Degrading Lacticaseibacillus paracasei NEFU-6 Application in Kimchi "Paocai". | Molecules | 2026 | https://conductscience.org/library/papers/42197271 | PubMed |
| 41846074 | Dietary effect of nano-encapsulated probiotics and alpha-lipoic acid in improving blood parameters, immunity, gut health, gene expression, and growth performance in heat-stressed broilers. | Poult Sci | 2026 | https://conductscience.org/library/papers/41846074 | PubMed |
| 41753671 | Serum Uric Acid-Reducing Effect and Intestinal Mucosal Barrier-Repairing Function of Limosilactobacillus reuteri MBHC10138. | Microorganisms | 2026 | https://conductscience.org/library/papers/41753671 | PubMed |
| 41465049 | Phenotypic Characterization and Genomic Mining of Uric Acid Catabolism Genes in Lactiplantibacillus plantarum YC. | Foods | 2025 | https://conductscience.org/library/papers/41465049 | PubMed |
| 41453990 | Investigating the mechanisms of lactulose on gut health and uric acid metabolism in geese via transcriptomics. | Sci Rep | 2025 | https://conductscience.org/library/papers/41453990 | PubMed |
| 41228519 | Lactiplantibacillus plantarum WLPL04 from Human Breast Milk Attenuates Hyperuricemia via Coordinated Purine Salvage Pathway, Renal Transporter Regulation, and Gut Microbiota Remodeling. | Nutrients | 2025 | https://conductscience.org/library/papers/41228519 | PubMed |
| 41127097 | Lactobacillus paracasei N1115 alleviates hyperuricemia in mice: regulation of uric acid metabolism as well as its impact on gut microbiota and short-chain fatty acids. | Front Nutr | 2025 | https://conductscience.org/library/papers/41127097 | PubMed |
| 40895468 | Hyperuricemia and the gut microbiota: current research hotspots and future trends. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40895468 | PubMed |
| 40316867 | Safety Evaluation of Human-Derived Uric Acid Degrading Lacticaseibacillus paracasei M2a and Its Impact on Gut Microbiota. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/40316867 | PubMed |
| 40149789 | Aggression and Justice Involvement: Does Uric Acid Play a Role? | Brain Sci | 2025 | https://conductscience.org/library/papers/40149789 | PubMed |
| 39949621 | The effects of Bifidobacterium animalis QC08 on reducing uric acid level and providing renal protection in mice with hyperuricemia. | Front Microbiol | 2025 | https://conductscience.org/library/papers/39949621 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39600720
GET https://conductscience.org/api/papers/v1/39600720/references?page=2